258 related articles for article (PubMed ID: 22664092)
1. Uropathogenic Escherichia coli mediated urinary tract infection.
Totsika M; Moriel DG; Idris A; Rogers BA; Wurpel DJ; Phan MD; Paterson DL; Schembri MA
Curr Drug Targets; 2012 Oct; 13(11):1386-99. PubMed ID: 22664092
[TBL] [Abstract][Full Text] [Related]
2. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
[TBL] [Abstract][Full Text] [Related]
3. Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic
Westcott MM; Morse AE; Troy G; Blevins M; Wierzba T; Sanders JW
Microbiol Spectr; 2024 Mar; 12(3):e0366123. PubMed ID: 38315025
[TBL] [Abstract][Full Text] [Related]
4. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
5. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
6. UroPathogenic
Terlizzi ME; Gribaudo G; Maffei ME
Front Microbiol; 2017; 8():1566. PubMed ID: 28861072
[TBL] [Abstract][Full Text] [Related]
7. The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity.
Lupo F; Ingersoll MA; Pineda MA
Immunology; 2021 Sep; 164(1):3-14. PubMed ID: 33763853
[TBL] [Abstract][Full Text] [Related]
8. [Urinary tract infections, immunity, and vaccination].
Luna-Pineda VM; Ochoa S; Cruz-Córdova A; Cázares-Domínguez V; Vélez-González F; Hernández-Castro R; Xicohtencatl-Cortes J
Bol Med Hosp Infant Mex; 2018; 75(2):67-78. PubMed ID: 29658949
[TBL] [Abstract][Full Text] [Related]
9. Proposed dual antagonist approach for the prevention and treatment of urinary tract infections caused by uropathogenic Escherichia coli.
Ribić R; Meštrović T; Neuberg M; Kozina G
Med Hypotheses; 2019 Mar; 124():17-20. PubMed ID: 30798908
[TBL] [Abstract][Full Text] [Related]
10. "Omics" Technologies - What Have They Told Us About Uropathogenic
Torres-Puig S; García V; Stærk K; Andersen TE; Møller-Jensen J; Olsen JE; Herrero-Fresno A
Front Cell Infect Microbiol; 2022; 12():824039. PubMed ID: 35237532
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
[TBL] [Abstract][Full Text] [Related]
13. Vaccination approaches for the prevention of urinary tract infection.
Moriel DG; Schembri MA
Curr Pharm Biotechnol; 2013; 14(11):967-74. PubMed ID: 24372245
[TBL] [Abstract][Full Text] [Related]
14. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.
Owrangi B; Masters N; Kuballa A; O'Dea C; Vollmerhausen TL; Katouli M
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):833-839. PubMed ID: 29340897
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?
Marrs CF; Zhang L; Foxman B
FEMS Microbiol Lett; 2005 Nov; 252(2):183-90. PubMed ID: 16165319
[TBL] [Abstract][Full Text] [Related]
16. Host-Derived Nitric Oxide and Its Antibacterial Effects in the Urinary Tract.
Svensson L; Poljakovic M; Demirel I; Sahlberg C; Persson K
Adv Microb Physiol; 2018; 73():1-62. PubMed ID: 30262107
[TBL] [Abstract][Full Text] [Related]
17. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
Zalewska-Piątek BM; Piątek RJ
Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
[TBL] [Abstract][Full Text] [Related]
18. Urinary Tract Infections Caused by Uropathogenic
Zhou Y; Zhou Z; Zheng L; Gong Z; Li Y; Jin Y; Huang Y; Chi M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445714
[TBL] [Abstract][Full Text] [Related]
19. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.
Subashchandrabose S; Hazen TH; Brumbaugh AR; Himpsl SD; Smith SN; Ernst RD; Rasko DA; Mobley HL
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18327-32. PubMed ID: 25489107
[TBL] [Abstract][Full Text] [Related]
20. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
O'Brien VP; Hannan TJ; Nielsen HV; Hultgren SJ
Microbiol Spectr; 2016 Feb; 4(1):. PubMed ID: 26999391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
